FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Robbiani, DF
   Olsen, PC
   Costa, F
   Wang, Q
   Oliveira, TY
   Nery, N
   Aromolaran, A
   do Rosario, MS
   Sacramento, GA
   Cruz, JS
   Khouri, R
   Wunder, EA
   Mattos, A
   Freitas, BD
   Sarno, M
   Archanjo, G
   Daltro, D
   Carvalho, GBS
   Pimentel, K
   de Siqueira, IC
   de Almeida, JRM
   Henriques, DF
   Lima, JA
   Vasconcelos, PFC
   Schaefer-Babajew, D
   Azzopardi, SA
   Bozzacco, L
   Gazumyan, A
   Belfort, R
   Alcantara, AP
   Carvalho, G
   Moreira, L
   Araujo, K
   Reis, MG
   Keesler, RI
   Coffey, LL
   Tisoncik-Go, J
   Gale, M
   Rajagopal, L
   Waldorf, KMA
   Dudley, DM
   Simmons, HA
   Mejia, A
   O'Connor, DH
   Steinbach, RJ
   Haese, N
   Smith, J
   Lewis, A
   Colgin, L
   Roberts, V
   Frias, A
   Kelleher, M
   Hirsch, A
   Streblow, DN
   Rice, CM
   MacDonald, MR
   de Almeida, ARP
   Van Rompay, KKA
   Ko, AI
   Nussenzweig, MC
AF Robbiani, Davide F.
   Olsen, Priscilla C.
   Costa, Federico
   Wang, Qiao
   Oliveira, Thiago Y.
   Nery Jr, Nivison
   Aromolaran, Adeolu
   do Rosario, Mateus S.
   Sacramento, Gielson A.
   Cruz, Jaqueline S.
   Khouri, Ricardo
   Wunder, Elsio A., Jr.
   Mattos, Adriana
   Freitas, Bruno de Paula
   Sarno, Manoel
   Archanjo, Gracinda
   Daltro, Dina
   Carvalho, Gustavo B. S.
   Pimentel, Kleber
   de Siqueira, Isadora C.
   de Almeida, Joo R. M.
   Henriques, Daniele F.
   Lima, Juliana A.
   Vasconcelos, Pedro F. C.
   Schaefer-Babajew, Dennis
   Azzopardi, Stephanie A.
   Bozzacco, Leonia
   Gazumyan, Anna
   Belfort Jr, Rubens
   Alcantara, Ana P.
   Carvalho, Gustavo
   Moreira, Licia
   Araujo, Katiaci
   Reis, Mitermayer G.
   Keesler, Rebekah, I
   Coffey, Lark L.
   Tisoncik-Go, Jennifer
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Waldorf, Kristina M. Adams
   Dudley, Dawn M.
   Simmons, Heather A.
   Mejia, Andres
   O'Connor, David H.
   Steinbach, Rosemary J.
   Haese, Nicole
   Smith, Jessica
   Lewis, Anne
   Colgin, Lois
   Roberts, Victoria
   Frias, Antonio
   Kelleher, Meredith
   Hirsch, Alec
   Streblow, Daniel N.
   Rice, Charles M.
   MacDonald, Margaret R.
   de Almeida, Antonio R. P.
   Van Rompay, Koen K. A.
   Ko, Albert, I
   Nussenzweig, Michel C.
TI Risk of Zika microcephaly correlates with features of maternal
   antibodies
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; PREGNANCY OUTCOMES;
   CROSS-REACTIVITY; INFECTION; DISEASE; TRANSMISSION; TERRITORIES; RNA
AB Zika virus (ZIKV) infection during pregnancy causes congenital abnormalities, including microcephaly. However, rates vary widely, and the contributing risk factors remain unclear. We examined the serum antibody response to ZIKV and other flaviviruses in Brazilian women giving birth during the 2015-2016 outbreak. Infected pregnancies with intermediate or higher ZIKV antibody enhancement titers were at increased risk to give birth to microcephalic infants compared with those with lower titers (P < 0.0001). Similarly, analysis of ZIKV-infected pregnant macaques revealed that fetal brain damage was more frequent in mothers with higher enhancement titers. Thus, features of the maternal antibodies are associated with and may contribute to the genesis of ZIKV-associated microcephaly.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Oliveira, Thiago Y.; Schaefer-Babajew, Dennis; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.
   [Azzopardi, Stephanie A.; Bozzacco, Leonia; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
   [Olsen, Priscilla C.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
   [Wang, Qiao] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
   [Nery Jr, Nivison; Sacramento, Gielson A.; Cruz, Jaqueline S.; Khouri, Ricardo; de Siqueira, Isadora C.; Reis, Mitermayer G.; Ko, Albert, I] Fundacao Oswald Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Aromolaran, Adeolu; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [do Rosario, Mateus S.; Mattos, Adriana; Freitas, Bruno de Paula; Archanjo, Gracinda; Daltro, Dina; Carvalho, Gustavo B. S.; Pimentel, Kleber] Hosp Geral Roberto Santos, Secreteria Saude Estado Bahia, Salvador, BA, Brazil.
   [Henriques, Daniele F.; Lima, Juliana A.; Vasconcelos, Pedro F. C.] Minist Saude Ananindeua, Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Freitas, Bruno de Paula; Belfort Jr, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Araujo, Katiaci] Hosp Alianca, Salvador, BA, Brazil.
   [Alcantara, Ana P.; Carvalho, Gustavo; Moreira, Licia] Hosp Santo Amaro, Salvador, BA, Brazil.
   [Keesler, Rebekah, I; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Coffey, Lark L.; Van Rompay, Koen K. A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Rajagopal, Lakshmi; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Simmons, Heather A.; Mejia, Andres] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Steinbach, Rosemary J.; Roberts, Victoria; Frias, Antonio; Kelleher, Meredith] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA.
   [Haese, Nicole; Colgin, Lois; Hirsch, Alec; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.
   [Lewis, Anne] Oregon Natl Primate Res Ctr, Pathol Serv Unit, Div Comparat Med, Beaverton, OR USA.
   [Haese, Nicole; Smith, Jessica; Hirsch, Alec; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
   [Frias, Antonio] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Bozzacco, Leonia] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
EM drobbiani@rockefeller.edu; nussen@rockefeller.edu
RI Haese, Nicole/AAN-4551-2020; Olsen, Priscilla C/I-8994-2012; Reis,
   Mitermayer/AAO-9742-2020; Robbiani, Davide F./AAF-7662-2019; de
   Siqueira, Isadora Cristina/R-9953-2016; Wunder, Elsio
   Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015; Costa,
   Federico/G-1838-2015; Nussenzweig, Michel/AAE-7292-2019; Oliveira,
   Thiago Yukio Kikuchi/ABF-5186-2020
OI Olsen, Priscilla C/0000-0002-8795-037X; Reis,
   Mitermayer/0000-0002-3051-9060; Robbiani, Davide F./0000-0001-7379-3484;
   de Siqueira, Isadora Cristina/0000-0002-2520-4099; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Ko, Albert Icksang/0000-0001-9023-2339;
   Costa, Federico/0000-0001-6951-2336; Oliveira, Thiago Yukio
   Kikuchi/0000-0002-2654-0879; Wang, Qiao/0000-0001-6416-1733;
   Schaefer-Babajew, Dennis/0000-0002-5380-2950; do Rosario,
   Mateus/0000-0001-7404-6392; Kelleher, Meredith/0000-0002-5313-004X;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5R01AI121207,
   R01TW009504, R25TW009338, U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, P01AI138938, R21AI129479, R01AI124690, U19AI057229,
   R01AI100989, R01AI133976, AI083019, AI104002, P51OD010425, P51 OD011092,
   R21-HD091032, R01-HD08633]; Rockefeller University Development Office;
   Fundacao de Amparo a Pesquisa do Estado da Bahia grant [PET0021/2016];
   National Institutes of Health Office of Research Infrastructure
   Programs/OD [P51OD011107, P51OD011106]; United States Food and Drug
   Administration [HHSF223201610542P]; DHHS/PHS/National Institutes of
   Health [R01Al116382-01A1]; Research Facilities Improvement ProgramUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [RR15459-01, RR020141-01]; Conselho Nacional de De-senvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [303999/2016-0, 439971/20016-0,
   440405/2016-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (Zika fast-track); Pew Latin American Fellows Program in the
   Biomedical Sciences; Studienstiftung des Deutschen Volkes; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI083019, U19AI111825,
   R21AI129479, R01AI121207, U19AI111825, U19AI083019, R01AI145296,
   U19AI083019, U19AI083019, R01AI121207, U19AI111825, U19AI083019,
   R21AI129479, U19AI111825, R01AI121207, U19AI111825, U19AI111825,
   U19AI083019, U19AI111825, U19AI083019, U19AI111825, U19AI111825,
   U19AI111825, U19AI111825, R01AI104002, U19AI111825, U19AI083019,
   U19AI111825, U19AI111825, U19AI083019, R01AI133976, U19AI111825,
   R01AI133976, U19AI083019, U19AI111825, U19AI111825, U19AI111825,
   U19AI111825, U19AI083019, U19AI083019, U19AI111825, R01AI121207,
   U19AI111825, U19AI111825, U19AI111825, U19AI083019, U19AI111825,
   U19AI083019, U19AI083019, U19AI111825, U19AI111825, U19AI083019,
   U19AI111825, R01AI145296, R01AI133976, U19AI083019, U19AI111825,
   U19AI083019, U19AI111825, R01AI104002] Funding Source: NIH RePORTER;
   OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [P51OD010425, P51OD010425, P51OD011092, P51OD011092, P51OD011092,
   P51OD010425, P51OD010425, P51OD011092, P51OD011092, P51OD011092,
   P51OD010425, P51OD011092, P51OD011092, P51OD010425, P51OD011092,
   P51OD011107, P51OD011092, P51OD010425, P51OD011106, P51OD011107,
   P51OD010425, P51OD011107, P51OD011106, P51OD010425, P51OD011092,
   P51OD011106, P51OD011092, P51OD010425, P51OD010425, P51OD011092,
   P51OD011092, P51OD010425, P51OD011092, P51OD010425, P51OD010425,
   P51OD011092, P51OD011107, P51OD011092, P51OD011092, P51OD011106,
   P51OD010425, P51OD011092, P51OD011107, P51OD010425, P51OD011092,
   P51OD011106, P51OD011107, P51OD011092, P51OD010425, P51OD011106,
   P51OD010425, P51OD011092, P51OD011092, P51OD011107, P51OD011107,
   P51OD011107, P51OD011092, P51OD011092, P51OD011107, P51OD011092,
   P51OD010425, P51OD011106, P51OD010425, P51OD010425, P51OD010425,
   P51OD011092, P51OD011092, P51OD011092, P51OD011107, P51OD010425,
   P51OD010425, P51OD011092, P51OD010425, P51OD010425, P51OD010425,
   P51OD011092, P51OD010425, P51OD011092, P51OD011107, P51OD011107,
   P51OD011092, P51OD011092, P51OD010425, P51OD011092, P51OD011092,
   P51OD011092, P51OD010425, P51OD011106, P51OD010425, P51OD011107,
   P51OD011092, P51OD011107, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD010425, P51OD011092] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health grants
   5R01AI121207, R01TW009504, and R25TW009338 to A.I. Ko; National
   Institutes of Health pilot awards U19AI111825 and UL1TR001866 to D.F.
   Robbiani; National Institutes of Health grants R01AI037526, UM1AI100663,
   U19AI111825, UL1TR001866, and P01AI138938 to M.C. Nussenzweig; National
   Institutes of Health grants R01AI124690 and U19AI057229 (Cooperative
   Center for Human Immunology pilot project); The Rockefeller University
   Development Office and anonymous donors (to C.M. Rice); Fundacao de
   Amparo a Pesquisa do Estado da Bahia grant PET0021/2016 (to M.G. Reis);
   National Institutes of Health grant R21AI129479-Supplement (to K.K.A.
   Van Rompay) and the National Institutes of Health Office of Research
   Infrastructure Programs/OD (P51OD011107 to the CNPRC); the United States
   Food and Drug Administration contract HHSF223201610542P (to L.L.
   Coffey); National Institutes of Health grants R01AI100989 and
   R01AI133976 (to L. Rajagopal and K.M. Adams Waldorf); and National
   Institutes of Health grants AI083019 and AI104002 (to M. Gale Jr.) and
   grant P51OD010425 to the WaNPRC (to K.M. Adams Waldorf, J. Tisoncik-Go,
   and M. Gale Jr.). Studies at WNPRC were supported by DHHS/PHS/National
   Institutes of Health grant R01Al116382-01A1 (to D.H. O'Connor), in part
   by the National Institutes of Health Office of Research Infrastructure
   Programs/OD (grant P51OD011106) awarded toWNPRC, at a facility
   constructed in part with support from Research Facilities Improvement
   Program grants RR15459-01 and RR020141-01; and National Institutes of
   Health core and pilot grant P51 OD011092 and grants R21-HD091032 and
   R01-HD08633 (to ONPRC). P.F.C. Vasconcelos was supported by Conselho
   Nacional de De-senvolvimento Cientifico e Tecnologico (projects
   303999/2016-0, 439971/20016-0, and 440405/2016-5) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Zika fast-track). P.C.
   Olsen is supported by the Pew Latin American Fellows Program in the
   Biomedical Sciences. D. Schaefer-Babajew is supported by Studienstiftung
   des Deutschen Volkes. F. Costa is a Wellcome Trust Fellow in Public
   Health and Tropical Medicine, and M.C. Nussenzweig is a Howard Hughes
   Medical Institute Investigator.
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Ministry of Health of Brazil, 2017, HLTH BRAZ 2015 2016
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282X20170066, 10.1590/0004-282x20170066]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 60
TC 11
Z9 11
U1 0
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT
PY 2019
VL 216
IS 10
BP 2302
EP 2315
DI 10.1084/jem.20191061
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JC2PM
UT WOS:000489118900009
PM 31413072
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Robbiani, DF
   Bozzacco, L
   Keeffe, JR
   Khouri, R
   Olsen, PC
   Gazumyan, A
   Schaefer-Babajew, D
   Avila-Rios, S
   Nogueira, L
   Patel, R
   Azzopardi, SA
   Uhl, LFK
   Saeed, M
   Sevilla-Reyes, EE
   Agudelo, M
   Yao, KH
   Golijanin, J
   Gristick, HB
   Lee, YE
   Hurley, A
   Caskey, M
   Pai, J
   Oliveira, T
   Wunder, EA
   Sacramento, G
   Nery, N
   Orge, C
   Costa, F
   Reis, MG
   Thomas, NM
   Eisenreich, T
   Weinberger, DM
   de Almeida, ARP
   West, AP
   Rice, CM
   Bjorkman, PJ
   Reyes-Teran, G
   Ko, AI
   MacDonald, MR
   Nussenzweig, MC
AF Robbiani, Davide F.
   Bozzacco, Leonia
   Keeffe, Jennifer R.
   Khouri, Ricardo
   Olsen, Priscilla C.
   Gazumyan, Anna
   Schaefer-Babajew, Dennis
   Avila-Rios, Santiago
   Nogueira, Lilian
   Patel, Roshni
   Azzopardi, Stephanie A.
   Uhl, Lion F. K.
   Saeed, Mohsan
   Sevilla-Reyes, Edgar E.
   Agudelo, Marianna
   Yao, Kai-Hui
   Golijanin, Jovana
   Gristick, Harry B.
   Lee, Yu E.
   Hurley, Arlene
   Caskey, Marina
   Pai, Joy
   Oliveira, Thiago
   Wunder, Elsio A., Jr.
   Sacramento, Gielson
   Nery, Nivison, Jr.
   Orge, Cibele
   Costa, Federico
   Reis, Mitermayer G.
   Thomas, Neena M.
   Eisenreich, Thomas
   Weinberger, Daniel M.
   de Almeida, Antonio R. P.
   West, Anthony P., Jr.
   Rice, Charles M.
   Bjorkman, Pamela J.
   Reyes-Teran, Gustavo
   Ko, Albert I.
   MacDonald, Margaret R.
   Nussenzweig, Michel C.
TI Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil
   and Mexico
SO CELL
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; MEDIATED
   NEUTRALIZATION; CROSS-REACTIVITY; DOMAIN-III; HIV-1; ENHANCEMENT; BROAD;
   GLYCOPROTEIN
AB Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and Mexico for ZIKV envelope domain III (ZEDIII) binding and neutralization. We find that serologic reactivity to dengue 1 virus (DENV1) EDIII before ZIKV exposure is associated with increased ZIKV neutralizing titers after exposure. Antibody cloning shows that donors with high ZIKV neutralizing antibody titers have expanded clones of memory B cells that express the same immunoglobulin VH3-23/VK1-5 genes. These recurring antibodies cross-react with DENV1, but not other flaviviruses, neutralize both DENV1 and ZIKV, and protect mice against ZIKV challenge. Structural analyses reveal the mechanism of recognition of the ZEDIII lateral ridge by VH3-23/VK1-5 antibodies. Serologic testing shows that antibodies to this region correlate with serumneutralizing activity to ZIKV. Thus, high neutralizing responses to ZIKV are associated with pre-existing reactivity to DENV1 in humans.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Nogueira, Lilian; Patel, Roshni; Uhl, Lion F. K.; Agudelo, Marianna; Yao, Kai-Hui; Golijanin, Jovana; Hurley, Arlene; Caskey, Marina; Pai, Joy; Oliveira, Thiago; Thomas, Neena M.; Eisenreich, Thomas; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Bozzacco, Leonia; Azzopardi, Stephanie A.; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Keeffe, Jennifer R.; Gristick, Harry B.; Lee, Yu E.; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Khouri, Ricardo; Wunder, Elsio A., Jr.; Sacramento, Gielson; Nery, Nivison, Jr.; Orge, Cibele; Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Avila-Rios, Santiago; Sevilla-Reyes, Edgar E.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Mexico City 14080, DF, Mexico.
   [Wunder, Elsio A., Jr.; Costa, Federico; Reis, Mitermayer G.; Weinberger, Daniel M.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med Bahia, BR-40296710 Salvador, BA, Brazil.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, BR-40296710 Salvador, BA, Brazil.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; MacDonald, MR (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
EM drobbiani@rockefeller.edu; macdonm@rockefeller.edu;
   nussen@rockefeller.edu
RI Wunder, Elsio Augusto/C-2733-2013; Reis, Mitermayer/AAO-9742-2020;
   Robbiani, Davide F./AAF-7662-2019; Avila-Rios, Santiago/AAB-4383-2020;
   Olsen, Priscilla C/I-8994-2012; Costa, Federico/G-1838-2015; Khouri,
   Ricardo/M-3184-2018; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago
   Yukio Kikuchi/ABF-5186-2020; Ko, Albert Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Reis,
   Mitermayer/0000-0002-3051-9060; Robbiani, Davide F./0000-0001-7379-3484;
   Olsen, Priscilla C/0000-0002-8795-037X; Costa,
   Federico/0000-0001-6951-2336; Khouri, Ricardo/0000-0001-5664-4436;
   Oliveira, Thiago Yukio Kikuchi/0000-0002-2654-0879; Ko, Albert
   Icksang/0000-0001-9023-2339; Uhl, Lion/0000-0003-1729-9857;
   Schaefer-Babajew, Dennis/0000-0002-5380-2950; Caskey,
   Marina/0000-0003-1727-8693; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, R01AI121207, R01TW009504, R25TW009338, U01AI088752,
   R01AI124690, U19AI057229]; Molecular Observatory at Caltech - Gordon and
   Betty Moore Foundation; Robertson Therapeutic Development Fund; Pew
   Latin American Fellows Program in the Biomedical Sciences;
   Studienstiftung des deutschen Volkes; Austrian Marshall Plan Foundation;
   Red INMUNOCANEI-Conacyt; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001866, UL1TR001866, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001866, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001866, UL1TR001866, UL1TR001866, UL1TR001863, UL1TR001866,
   UL1TR001866, UL1TR001866] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI111825, R21AI112602, U19AI111825, U19AI111825, T32AI070084,
   U19AI111825, U19AI111825, R01AI037526, R01AI037526, UM1AI100663,
   UM1AI100663, U19AI111825, U19AI111825, R01AI037526, R01AI121207,
   U19AI111825, U19AI111825, U01AI088752, UM1AI100663, R01AI037526,
   T32AI070084, R01AI124690, R01AI037526, R01AI124690, U19AI111825,
   UM1AI100663, R01AI037526, R01AI121207, UM1AI100663, U19AI111825,
   U19AI111825, U19AI111825, U19AI111825, UM1AI100663, U19AI111825,
   R01AI121207, U19AI111825, UM1AI100663, UM1AI100663, U19AI111825,
   UM1AI100663, UM1AI100663, U01AI088752, UM1AI100663, U19AI111825,
   R01AI124690, R37AI037526, UM1AI100663, UM1AI100663, UM1AI100663,
   UM1AI100663, UM1AI100663, UM1AI100663, U19AI111825, UM1AI100663,
   U19AI111825, UM1AI100663, UM1AI100663, U19AI111825, UM1AI100663,
   U19AI111825, R01AI037526, UM1AI100663, U19AI111825, U19AI111825,
   U19AI111825, R01AI037526, U19AI111825, UM1AI100663, R21AI112602,
   UM1AI100663, UM1AI100663, UM1AI100663, UM1AI100663, R37AI037526,
   U19AI111825, UM1AI100663, UM1AI100663, UM1AI100663, R01AI037526,
   U19AI111825, U01AI088752, U19AI111825, R01AI037526, U19AI111825,
   R37AI037526, R01AI037526, R01AI121207, UM1AI100663, UM1AI100663,
   U19AI111825, U19AI111825, UM1AI100663, UM1AI100663, U19AI111825,
   U19AI111825, R01AI124690, R01AI037526, UM1AI100663, R01AI037526,
   U19AI111825, UM1AI100663, UM1AI100663, U19AI111825, R37AI037526,
   U19AI111825, UM1AI100663, UM1AI100663, U19AI111825, UM1AI100663,
   UM1AI100663, UM1AI100663, U19AI111825, U19AI111825, UM1AI100663,
   UM1AI100663, UM1AI100663, U19AI111825, R01AI037526, UM1AI100663,
   UM1AI100663, U19AI111825, R01AI037526, UM1AI100663, UM1AI100663,
   UM1AI100663, T32AI070084, R01AI037526, R01AI121207, U19AI111825,
   U19AI111825, UM1AI100663, U19AI111825, R01AI037526, U01AI088752,
   R37AI037526, UM1AI100663, R01AI124690, UM1AI100663, UM1AI100663,
   UM1AI100663, UM1AI100663, R01AI037526, U01AI088752, U01AI088752,
   U19AI111825, U19AI111825, UM1AI100663, U19AI111825, T32AI070084,
   UM1AI100663, R37AI037526, R37AI037526, R01AI037526] Funding Source: NIH
   RePORTER
FX We would especially like to thank the members of the Santa Maria
   Mixtequilla and Pau da Lima communities who agreed to participate in
   this study, as well as the Fiocruz community research team and staff of
   Hospital Geral Roberto Santos for their assistance with the clinical
   protocols. We thank members of the Nussenzweig and Rice labs for helpful
   discussions and suggestions. A particular thank you to Lotta von
   Boehmer, Christian Mayer, Yotam Bar-On, Irina Shimeliovich, and Julio
   Cetrulo Lorenzi for sharing expertise, protocols, and reagents. We thank
   Ted Pierson for plasmids pWNVII-Rep-REN-IB and pZIKV/HPF/CprME, Aaron
   Brault (CDC) for ZIKV PRVABC59, Bob Tesh for DENV1 PUO-359, Matt Evans
   for ZIKV MR766 cDNA, and Greg Ebel, James Weger, and Brian Geiss for
   ZIKV PRVABC59 cDNA. We are grateful to Laura Kramer (NYSDOH) and Robert
   Lanciotti (CDC) for PRNT advice and protocols, Kimberly Dowd for RVP
   advice, and Muhammad Arshad for cloning assistance. We thank Barbara
   Johnson, Ann Powers, Christin Goodman, Claire Huang, Brandy Russell
   (CDC), and Claudia Duarte dos Santos for sharing ZIKV information early
   on. Moreover, we are thankful to Mary Ellen Castillo for facilitating
   virus work in the cell culture core, Alison Ashbrook for help with PRNT
   assays, Natalia Frias-Staheli for generation of the DENV1 stock, Corrine
   Quirk for assistance with mouse colonies, Tiffany Luong, Alisa Voll, and
   the Caltech Protein Expression Center for cloning, expression, and
   purification of proteins for crystallography, and Christopher Barnes and
   Beth Stadtmueller for help with crystallographic methods. This work was
   supported by NIH pilot awards U19AI111825 (to D.F.R.) and UL1TR001866
   (to D.F.R. and L.B.), grants R01AI037526, UM1AI100663, U19AI111825, and
   UL1TR001866 (to M.C.N.), grants R01AI121207, R01TW009504, R25TW009338,
   and U01AI088752 (to A.I.K.), grants R01AI124690 (to C.M.R.) and
   U19AI057229 (CCHI Opportunity Fund Project to C.M.R. and M.R.M.), donors
   to the Zika Fund at Rockefeller University and anonymous donors (to
   C.M.R.), and the Molecular Observatory at Caltech supported by the
   Gordon and Betty Moore Foundation (P.J.B.). Operations at the Stanford
   Synchrotron Radiation Lightsource are supported by the US Department of
   Energy and the NIH. Support was also provided by the Robertson
   Therapeutic Development Fund (to D.F.R. and M.C.N.). P.C.O. is supported
   by the Pew Latin American Fellows Program in the Biomedical Sciences,
   D.S.-B. by Studienstiftung des deutschen Volkes, L.F.K.U. by the
   Austrian Marshall Plan Foundation, and E.E.S.-R. is partly supported by
   Red INMUNOCANEI-Conacyt. M.C.N. is an HHMI Investigator. In connection
   with this work, D.F.R. and M.C.N. have a provisional patent application
   with the U.S. Patent and Trademark Office (62/483,001). The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of any of the funding agencies or
   individuals.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L., 2016, EURO SURVEILL, V21
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509
   Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774
   SABIN AB, 1950, BACTERIOL REV, V14, P225
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942
   von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110
   West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
NR 73
TC 123
Z9 125
U1 0
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 4
PY 2017
VL 169
IS 4
BP 597
EP 609
DI 10.1016/j.cell.2017.04.024
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ET8PD
UT WOS:000400560900007
PM 28475892
OA Bronze, Green Accepted
DA 2020-12-08
ER

PT J
AU Sarno, M
   Sacramento, GA
   Khouri, R
   do Rosario, MS
   Costa, F
   Archanjo, G
   Santos, LA
   Nery, N
   Vasilakis, N
   Ko, AI
   de Almeida, ARP
AF Sarno, Manoel
   Sacramento, Gielson A.
   Khouri, Ricardo
   do Rosario, Mateus S.
   Costa, Federico
   Archanjo, Gracinda
   Santos, Luciane A.
   Nery, Nivison, Jr.
   Vasilakis, Nikos
   Ko, Albert I.
   de Almeida, Antonio R. P.
TI Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis,
   Hydranencephaly and Fetal Demise
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK; BRAZIL
AB Background
   The rapid spread of Zika virus in the Americas and current outbreak of microcephaly in Brazil has raised attention to the possible deleterious effects that the virus may have on fetuses.
   Methodology/Principal Findings
   We report a case of a 20-year-old pregnant woman who was referred to our service after a large Zika virus outbreak in the city of Salvador, Brazil with an ultrasound examination that showed intrauterine growth retardation of the fetus at the 18th gestational week. Ultrasound examinations in the 2nd and 3rd trimesters demonstrated severe microcephaly, hydranencephaly, intracranial calcifications and destructive lesions of posterior fossa, in addition to hydrothorax, ascites and subcutaneous edema. An induced labor was performed at the 32nd gestational week due to fetal demise and delivered a female fetus. ZIKV-specific real-time polymerase chain reaction amplification products were obtained from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid, while extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products.
   Conclusions/Significance
   This case report provides evidence that in addition to microcephaly, there may be a link between Zika virus infection and hydrops fetalis and fetal demise. Given the recent spread of the virus, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
C1 [Sarno, Manoel; do Rosario, Mateus S.; Archanjo, Gracinda; de Almeida, Antonio R. P.] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Sacramento, Gielson A.; Khouri, Ricardo; Costa, Federico; Santos, Luciane A.; Nery, Nivison, Jr.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM albert.ko@yale.edu
RI Costa, Federico/G-1838-2015; Pinto, Marcelo/G-7503-2012; Khouri,
   Ricardo/M-3184-2018; Vasilakis, Nikos/ABE-7318-2020; Ko, Albert
   Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Pinto, Marcelo/0000-0003-3462-7277;
   Khouri, Ricardo/0000-0001-5664-4436; Ko, Albert
   Icksang/0000-0001-9023-2339; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; do Rosario, Mateus/0000-0001-7404-6392
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER; FIC NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01 TW009504] Funding Source: Medline; NIAID
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI121207] Funding Source: Medline
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazil Ministry of Health, 2016, 11 BRAZ MIN HLTH
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A, 2016, ZIKA VIRUS AM YET AN
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 11
TC 210
Z9 216
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2016
VL 10
IS 2
AR e0004517
DI 10.1371/journal.pntd.0004517
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1TH
UT WOS:000372567300081
PM 26914330
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

EF